Ipca Laboratories Q2 Net down 53 pc to Rs 61.30 cr

Drug firm Ipca Laboratories today reported a 52.64 per cent dip in standalone net profit to Rs 61.30 crore for the quarter ended September 30, 2014, mainly on account of subdued exports.
The company had posted a net profit of Rs 129.45 crore for the corresponding period of the previous fiscal.
Standalone total income from operations has also reduced to Rs 780.60 crore for the quarter under consideration as against Rs 846.70 crore for the same period year ago, Ipca Laboratories said in a filing to the BSE.
"Exports income came down 23 per cent at Rs 402.44 crore," the company said.

Shares of Ipca Laboratories settled at Rs 637.25 on BSE, down 3.64 per cent from previous close.